Atosiban and Rutin exhibit anti-mycobacterial activity - An integrated computational and biophysical insight toward drug repurposing strategy against Mycobacterium tuberculosis targeting its essential enzyme HemD.
In: International journal of biological macromolecules, Jg. 253 (2023-12-31), Heft Pt 6, S. 127208
academicJournal
Zugriff:
With the advancements of high throughput computational screening procedures, drug repurposing became the privileged framework for drug discovery. The structure-based drug discovery is the widely used method of drug repurposing, consisting of computational screening of compounds and testing them in-vitro. This current method of repurposing leaves room for mechanistic insights into how these screened hits interact with and influence their targets. We addressed this gap in the current study by integrating highly sensitive biophysical methods into existing computational repurposing methods. We also corroborated our computational and biophysical findings on H37Rv for the anti-mycobacterial action of selected drugs in-vitro and ex-vivo conditions. Atosiban and Rutin were screened as highly interacting hits against HemD through multi-stage docking and were cross-validated in biophysical studies. The affinity of these drugs (K ~ 10 6 M -1 ) was quantified using fluorescence quenching studies. Differential Scanning Fluorimetry (DSF) and urea-based chemical denaturation studies revealed a destabilizing effect of these drugs on target which was further validated using MD simulations. Conformational rearrangements of secondary structures were established using CD spectra and intrinsic fluorescence. Furthermore, Atosiban and Rutin inhibited M.tb growth in-vitro and ex-vivo while remaining non-toxic to mice peritoneal macrophages.
Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
(Copyright © 2023 Elsevier B.V. All rights reserved.)
Titel: |
Atosiban and Rutin exhibit anti-mycobacterial activity - An integrated computational and biophysical insight toward drug repurposing strategy against Mycobacterium tuberculosis targeting its essential enzyme HemD.
|
---|---|
Autor/in / Beteiligte Person: | Sharma, R ; Muthu, SA ; Agarwal, M ; Mehto, NK ; Pahuja, I ; Grover, A ; Dwivedi, VP ; Ahmad, B ; Grover, S |
Zeitschrift: | International journal of biological macromolecules, Jg. 253 (2023-12-31), Heft Pt 6, S. 127208 |
Veröffentlichung: | Amsterdam : Elsevier ; <i>Original Publication</i>: Guildford, Eng., IPC Science and Technology Press., 2023 |
Medientyp: | academicJournal |
ISSN: | 1879-0003 (electronic) |
DOI: | 10.1016/j.ijbiomac.2023.127208 |
Schlagwort: |
|
Sonstiges: |
|